Randox Cerebral arrays are designed for the simultaneous measurement of analytes associated with nervous system dysfunctions such as cerebrovascular disease, Alzheimer’s disease and Multiple Sclerosis (MS). Neurological disorders can affect the central, somatic and autonomic nervous system. At the molecular level, many analytes have been found to be involved in the pathophysiology of this complex interacting system. Proteins such as neuron specific enolase (NSE) are considered to be neurochemical markers of brain damage due to stroke or head injury and also appear to have predictive value for outcome after acute stroke. BDNF and GFAP among others have also been linked to Alzheimer’s disease and MS. Inflammatory processes have increasingly been shown to be implicated in the pathogenesis of...Read more
Receive your quote directly from Randox Laboratories Ltd..